SIRT4 and metabolic dysfunction-associated steatohepatitis: In conclusion, the present work showed that ferroptosis contributes to the pathogenesis of liver fibrosis in NASH with T2DM by promoting hepatocyte EMT, and that AGER1 can ameliorate liver fibrosis through inhibiting ferroptosis by regulating Sirt4.